News Caplin Point Laboratories Limited NSE India S.E.

Equities

CAPLIPOINT

INE475E01026

Market Closed - NSE India S.E. Other stock markets 09:03:21 2024-04-25 am EDT			5-day change	1st Jan Change
1,357 ^INR	+1.58%		+3.09%	+0.07%

Apr. 16	Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	MT
Mar. 28	Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	Apr. 16	MT
Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	Mar. 28	MT
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	Mar. 28	CI
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	Mar. 27	MT
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	Mar. 27	CI
Transcript : Caplin Point Laboratories Limited, Q3 2024 Earnings Call, Feb 09, 2024	Feb. 09
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09	CI
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	Jan. 08	MT
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	Jan. 08	MT
Caplin Point Laboratories Limited Announces Resignation of Hero Velladurai as President, R&D	Dec. 14	CI
Transcript : Caplin Point Laboratories Limited, H1 2024 Earnings Call, Nov 09, 2023	Nov. 09
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 09	CI
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	23-09-22	CI
Final dividend	23-09-13	FA
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	23-09-04	MT
Transcript : Caplin Point Laboratories Limited, Q1 2024 Earnings Call, Aug 08, 2023	23-08-08
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-07	CI
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	23-08-07	CI
Caplin Point Laboratories to Incorporate Step-Down Subsidiary in US	23-08-03	MT
Caplin Point Unit Gets US FDA Nod for Muscle Relaxant	23-06-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Caplin Point Laboratories Limited NSE India S.E.

Equities

CAPLIPOINT

INE475E01026

Summary

Filters